Skip to main content
. 2020 Jun 1;19:79. doi: 10.1186/s12939-020-01200-9

Table 3.

Clinical outcome of recipients based on type of donor

Living (n = 217) Deceased (n = 199) p-value‡
n (%) n (%)
Medical events .04
Acute Rejection 13(6) 17 (8.5) .60
ATN 36 (16.6) 54 (27.13) .03
DGF 43 (19.8) 68 (34.17) .004
Arrhythmia 7 (3.22) 7 (3.5) .97
Myocardial infarction 0 (0) 7 (3.5) .02
Pulmonary emboli 3 (1.38) 3 (1.5) .99
Infection 9 (4.15) 6 (3.01) .82
Surgical events .08
Hemorrhage 10 (4.6) 8 (4.02)
Vascular thrombosis 1 (0.46) 5 (2.51)
Ureteral complication 3 (1.38) 3 (1.5)
Surgical site infection 2 (0.92) 3 (1.5)

Lab Data

mean (SD)

Before Transplant→ After Transplant Before Transplant→ After Transplant p-value†
Hb 11.09 (2.28) → 10.05 (1.72) 11.54 (2.03) → 9.5 (1.49) .04
WBC 10.40 (14.7) → 13.92 (13.20) 8.92 (7.26) → 10.39 (6.59) .22
PLT 184.98 (61.8) → 189.61 (64.8) 196.95 (99.5) → 186.36 (66.0) .15
AST 17.47 (9.11) → 26.60 (16.76) 20.04 (13.62) → 89.26 (7.65) .03
ALT 19.22 (10.98) → 43.71 (49.43) 20.86 (18.40) → 40.91 (62.83) .30
ALP 286.43(226.26) → 129.40 (16.67) 319.30 (237.57) → 131.38 (14.90) .19

‡ Chi- square test

† Paired t-test

ESRD, end stage renal disease. ADPKD, autosomal dominant polycystic kidney disease. ATN, acute tubular necrosis. DGF, delayed graft function. Lab data, laboratory data. Hb, hemoglobin. WBC, white blood cell. PLT, platelet. AST, aspartate aminotransferase. ALT, alanine aminotransferase. ALP, alkaline phosphatase